News

ATUM in the News
February 18, 2025
Developing stable cell lines is a complex, time-intensive process involving numerous steps.
July 9, 2024
The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies
February 22, 2024
Mitigating the aggregation challenge in immunocytokine production: Strategies during cell line development and purification optimization
February 6, 2024
Directed Evolution for Protein Engineering
January 10, 2024
Pharma Turns to New Tech for Biologics
January 4, 2024
Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters

Share

Search